Il-18, Vcam-1 and P-Selectin As Early Biomarkers in Normoalbuminuric Type 2 Diabetes Patients
- 1 April 2019
- journal article
- research article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 13 (6) , 467-478
Abstract
Aim: To investigate the pathophysiological role of different biomarkers in diabetic kidney disease (DKD) among normoalbuminuric patients with a low-estimated glomerular filtration rate (eGFR). Meth...Keywords
Funding Information
- King Abdulaziz City for Science and Technology (A-T-34-194)
This publication has 24 references indexed in Scilit:
- Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patientsScientific Reports, 2017
- Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic NephropathyCanadian Journal of Kidney Health and Disease, 2017
- Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta AnalysisPLOS ONE, 2016
- Comparison of serum levels of IL-18 in peripheral blood of patients with type II diabetes with nephropathy clinical protests and patients with type II diabetes without nephropathy clinical protestsDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2016
- Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to MacroalbuminuriaDiabetes Care, 2013
- Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal FunctionDiabetes Care, 2013
- Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United StatesJAMA, 2011
- Tubular biomarkers to assess progression of diabetic nephropathyKidney International, 2011
- The role of interleukin-18 in the metabolic syndromeCardiovascular Diabetology, 2010
- Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease PatientClinical Journal of the American Society of Nephrology, 2008